Search results for "Monoaminergic"

showing 10 items of 12 documents

Extended Flight Bouts Require Disinhibition from GABAergic Mushroom Body Neurons

2019

Summary Insect flight is a complex behavior that requires the integration of multiple sensory inputs with flight motor output. Although previous genetic studies identified central brain monoaminergic neurons that modulate Drosophila flight, neuro-modulatory circuits underlying sustained flight bouts remain unexplored. Certain classes of dopaminergic and octopaminergic neurons that project to the mushroom body, a higher integrating center in the insect brain, are known to modify neuronal output based on contextual cues and thereby organismal behavior. This study focuses on how monoaminergic modulation of mushroom body GABAergic output neurons (MBONs) regulates the duration of flight bouts. O…

0301 basic medicineMale[SDV]Life Sciences [q-bio]Sensory systemBiologyin-vivoInsect flightGeneral Biochemistry Genetics and Molecular Biologymemory03 medical and health sciences0302 clinical medicineoctopaminebodiesexpressionMonoaminergicmedicineAnimalsGABAergic NeuronsMushroom Bodies030304 developmental biologymarker0303 health sciencesbehaviorFlight initiation[SDV.BA]Life Sciences [q-bio]/Animal biologyDopaminergicOambdrosophilaCaMPARI030104 developmental biologyDrosophila melanogasternervous systemDisinhibitionFood searchFlight AnimalMushroom bodiesPAMGABAergicFemaledopaminemedicine.symptomsub-esophageal zone.General Agricultural and Biological SciencescircuitNeuroscience030217 neurology & neurosurgerySSRN Electronic Journal
researchProduct

Selective α-synuclein knockdown in monoamine neurons by intranasal oligonucleotide delivery: potential therapy for parkinson’s disease

2018

Progressive neuronal death in brainstem nuclei and widespread accumulation of α-synuclein are neuropathological hallmarks of Parkinson’s disease (PD). Reduction of α-synuclein levels is therefore a potential therapy for PD. However, because α-synuclein is essential for neuronal development and function, α-synuclein elimination would dramatically impact brain function. We previously developed conjugated small interfering RNA (siRNA) sequences that selectively target serotonin (5-HT) or norepinephrine (NE) neurons after intranasal administration. Here, we used this strategy to conjugate inhibitory oligonucleotides, siRNA and antisense oligonucleotide (ASO), with the triple monoamine reuptake …

0301 basic medicineanimal diseasesDopamineOligonucleotidesGene ExpressionPharmacologySynaptic TransmissionPrefrontal cortexMiceDA neurotransmission0302 clinical medicineDrug DiscoveryMonoaminergicNeural PathwaysRNA Small InterferingCells Cultured5-HT neurotransmissionChemistryGene Transfer TechniquesParkinson DiseaseVentral tegmental areaSubstantia Nigramedicine.anatomical_structureCaudate putamenGene Knockdown Techniquesalpha-SynucleinMolecular MedicineRNA InterferenceOriginal ArticleMonoamine reuptake inhibitormedicine.drugSignal TransductionSerotoninSubstantia nigraASO03 medical and health sciencesProsencephalonα-synucleinDopamineIntranasal administrationGeneticsmedicineAnimalsHumansMolecular BiologyAdministration IntranasalPharmacologyPars compactaDopaminergic NeuronsGenetic TherapyCorpus Striatumnervous system diseases030104 developmental biologyMonoamine neurotransmitterGene Expression Regulationnervous systemsiRNAParkinson’s diseaseLocus coeruleus030217 neurology & neurosurgery
researchProduct

Characterization of the transporterB0AT3 (Slc6a17) in the rodent central nervous system.

2013

Abstract Background The vesicular B0AT3 transporter (SLC6A17), one of the members of the SLC6 family, is a transporter for neutral amino acids and is exclusively expressed in brain. Here we provide a comprehensive expression profile of B0AT3 in mouse brain using in situ hybridization and immunohistochemistry. Results We confirmed previous expression data from rat brain and used a novel custom made antibody to obtain detailed co-labelling with several cell type specific markers. B0AT3 was highly expressed in both inhibitory and excitatory neurons. The B0AT3 expression was highly overlapping with those of vesicular glutamate transporter 2 (VGLUT2) and vesicular glutamate transporter 1 (VGLUT1…

Central Nervous SystemMaleSerotonin reuptake inhibitorVesicular glutamate transporter 1Central nervous systemVesicular Transport ProteinsNerve Tissue ProteinsIn situ hybridizationPharmacology and ToxicologyPharmacologyBiologyPlasma Membrane Neurotransmitter Transport ProteinsRats Sprague-DawleyCellular and Molecular NeuroscienceGlutamatergicMiceDopaminePregnancyMonoaminergicmedicineAnimalsRats WistarCells CulturedNeuronsGeneral NeuroscienceNeurosciencesTransporterFarmakologi och toxikologiEmbryo MammalianAntidepressive AgentsRatsMice Inbred C57BLProtein Transportmedicine.anatomical_structureGene Expression Regulationbiology.proteinFemaleFood DeprivationNeurovetenskapermedicine.drugResearch ArticleBMC neuroscience
researchProduct

Behavioural and neurochemical effects after repeated administration of N-ethylpentylone (ephylone) in mice

2022

N-ethyl-pentylone (NEP), also known as "ephylone" and N-ethylnorpentylone, has been identified as one of the most recent novel psychostimulants to emerge into the illicit drug market and it has been associated with some intoxications and even fatalities. However, little is known about the consequences of its repeated consumption as well as the role of the monoaminergic system in such consequences. Thus, the aim of our study was to investigate the neurochemical profile and the behavioural effects after both acute and repeated NEP exposure. Male OF1 mice were acutely (1, 3, 10 mg/kg, i.p.) or repeatedly (1, 3, 10 mg/kg, i.p., 5 days, twice/day) exposed to NEP, and anxiety-like behaviour, aggr…

HyperthermiaMaleDrugs of abusemedicine.medical_specialtymedicine.drug_classStimulantsStriatumButylaminesBiochemistryAnxiolyticCellular and Molecular NeuroscienceMiceNeurochemicalAggressivenessInternal medicineMonoaminergicmedicineAnimalsBenzodioxolesPrefrontal cortexBehavior Animalbusiness.industryfungiEstimulantsmedicine.diseaseEndocrinologySocial explorationCentral Nervous System StimulantsSerotoninDroguesAgressivitatbusiness
researchProduct

Depressive-like symptoms in a reserpine-induced model of fibromyalgia in rats.

2015

Since the pathogenesis of fibromyalgia is unknown, treatment options are limited, ineffective and in fact based on symptom relief. A recently proposed rat model of fibromyalgia is based on central depletion of monamines caused by reserpine administration. This model showed widespread musculoskeletal pain and depressive-like symptoms, but the methodology used to measure such symptoms has been criticized. Evidence relates the high prevalence of pain and depression in fibromyalgia to common pathogenic pathways, most probably focused on the monoaminergic system. The present study aims at a validation of the reserpine model of fibromyalgia. For this purpose, rats undergoing this model have been …

MalePain ThresholdFood deprivationmedicine.medical_specialtyFibromyalgiaReserpineTime FactorsPhysiologyExperimental and Cognitive PsychologyMotor ActivityOpen fieldRats Sprague-DawleyBehavioral NeuroscienceAnimal modelFibromyalgiaMonoaminergicMedicineAnimalsDepression (differential diagnoses)Adrenergic Uptake Inhibitorsbusiness.industryDepressionFeeding BehaviorReserpinemedicine.diseaseTest adaptationRatsDisease Models AnimalInhibition PsychologicalHindlimb SuspensionPhysical therapyExploratory Behaviorbusinessmedicine.drugPhysiologybehavior
researchProduct

Hippocampal oscillatory dynamics and sleep atonia are altered in an animal model of fibromyalgia: Implications in the search for biomarkers

2019

The pathogenesis of fibromyalgia is still unknown. Core symptoms include pain, depression, and sleep disturbances with high comorbidity, suggesting alterations in the monoaminergic system as a common origin of this disease. The reserpine-induced myalgia (RIM) model lowers pain thresholds and produces depressive-like symptoms. The present work aims to evaluate temporal dynamics in the oscillatory profiles and motor activity during sleep in this model and to evaluate if the model mimics the sleep disorders that occur in fibromyalgia patients. Hippocampal and electromyogram activity were recorded in chronically implanted rats. Following 3 days of basal recordings, reserpine was administered on…

MaleSleep Wake Disorders0301 basic medicinemyalgiaFibromyalgiaReserpineHippocampusElectromyographyHippocampal formationBiologyHippocampusRats Sprague-Dawley03 medical and health sciences0302 clinical medicineFibromyalgiaMonoaminergicmedicineAnimalsmedicine.diagnostic_testGeneral NeuroscienceChronic painElectroencephalographymedicine.diseaseBrain WavesSleep in non-human animalsRats030104 developmental biologymedicine.symptomSleepNeuroscience030217 neurology & neurosurgeryAntipsychotic AgentsJournal of Comparative Neurology
researchProduct

Impaired cannabinoid receptor type 1 signaling interferes with stress-coping behavior in mice.

2007

Dysregulation of the endocannabinoid system is known to interfere with emotional processing of stressful events. Here, we studied the role of cannabinoid receptor type 1 (CB1) signaling in stress-coping behaviors using the forced swim test (FST) with repeated exposures. We compared effects of genetic inactivation with pharmacological blockade of CB1 receptors both in male and female mice. In addition, we investigated potential interactions of the endocannabinoid system with monoaminergic and neurotrophin systems of the brain. Naive CB1 receptor-deficient mice (CB1-/-) showed increased passive stress-coping behaviors as compared to wild-type littermates (CB1+/+) in the FST, independent of se…

Malemedicine.medical_specialtyCannabinoid receptormedicine.medical_treatmentBiologyPharmacologyHippocampusMicePiperidinesReceptor Cannabinoid CB1Internal medicineCannabinoid receptor type 1MonoaminergicAdaptation PsychologicalGeneticsmedicineAnimalsBiogenic MonoaminesRNA MessengerReceptorMonoamine OxidaseSwimmingPharmacologyBrain-derived neurotrophic factormusculoskeletal neural and ocular physiologyBrain-Derived Neurotrophic FactorDesipraminefood and beveragesEndocannabinoid systemMice Inbred C57BLMonoamine neurotransmitterEndocrinologynervous systemVesicular Glutamate Transport Protein 1Molecular MedicinePyrazoleslipids (amino acids peptides and proteins)FemaleCannabinoidRimonabantpsychological phenomena and processesStress PsychologicalSignal TransductionThe pharmacogenomics journal
researchProduct

Wasp venom injected into the prey's brain modulates thoracic identified monoaminergic neurons.

2005

The wasp Ampulex compressa injects a cocktail of neurotoxins into the brain of its cockroach prey to induce an enduring change in the execution of locomotory behaviors. Our hypothesis is that the venom injected into the brain indirectly alters the activity of monoaminergic neurons, thus changing the levels of monoamines that tune the central synapses of locomotory circuits. The purpose of the present investigation was to establish whether the venom alters the descending control, from the brain, of octopaminergic neurons in the thorax. This question was approached by recording the activity of specific identified octopaminergic neurons after removing the input from the brain or after a wasp s…

Malemedicine.medical_treatmentWaspsVenomSensory systemWasp VenomsMotor ActivityMembrane PotentialsCellular and Molecular Neurosciencebiology.animalMonoaminergicmedicineAnimalsPeriplanetaOctopamineNeuronsCockroachbiologyGeneral NeuroscienceBrainInsect Bites and StingsAxotomyThoraxElectrophysiologyElectrophysiologyMonoamine neurotransmittermedicine.anatomical_structurenervous systemNeuronAxotomyNeuroscienceJournal of neurobiology
researchProduct

Animal Models of Stress - Current Knowledge and Potential Directions

2021

Finding new therapies and new antidepressant agents is of high clinical priority given that many cases of depressive disorder do not respond to conventional monoaminergic antidepressants such as selective serotonin reuptake inhibitors, tricyclic antidepressants, and monoamine oxidase inhibitors The authors demonstrated that electroacupuncture and fluoxetine, a second-generation antidepressant categorized as a selective serotonin reuptake inhibitor (Perez-Caballero et al , 2014), regulate the expression of key proteins in the calmodulin kinase (CAMK) signaling pathway, which are related to depression in the hippocampi of rats (Takemoto-Kimura et al , 2017;Xie et al , 2019) In a paper on “Sho…

Monoamine oxidaseCognitive NeuroscienceSerotonin reuptake inhibitorContext (language use)Pharmacologyalternative therapylcsh:RC321-571stress03 medical and health sciencesBehavioral Neurosciencechemistry.chemical_compound0302 clinical medicineorganoselenium compoundsMonoaminergicmedicineNeurotransmitterlcsh:Neurosciences. Biological psychiatry. Neuropsychiatry030304 developmental biologychemistry.chemical_classification0303 health sciencesFluoxetinebusiness.industryanimal modelsEditorialNeuropsychology and Physiological PsychologychemistryAntidepressantmajor depressionbusiness030217 neurology & neurosurgeryTricyclicmedicine.drugFrontiers in Behavioral Neuroscience
researchProduct

Neuronal and neuroendocrine mechanisms of social rank and stress coping in teleost fish

2015

Fights for social dominance are stressful and results in an activation of the brain serotonergic system. Subordinate animals in an established dominance hierarchy are characterized by a chronic elevation of brain serotonergic activity, an effect that seems to mediate the behavioural inhibition observed in these animals. By contrast, social dominance has been associated with elevated dopaminergic activity, and dopamine (DA) has behavioural effects to some extent opposing those of serotonin (5HT). In addition to effects of the social environment, brain monoaminergic functions are controlled by genetic factors. For instance, zebrafish (Danio rerio) classified as bold, showing a propensity for …

animal structuresanimal diseasesfungiDopaminergicDanioPhysiologyBiologySerotonergicbiology.organism_classificationBiochemistryDominance hierarchyDominance (ethology)DopamineMonoaminergicGeneticsmedicineSerotoninMolecular BiologyNeuroscienceBiotechnologymedicine.drugThe FASEB Journal
researchProduct